Søren Lund Kristensen
Søren Lund Kristensen publishes mostly in Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Epidemiology, on topics such as Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors and Atrial Fibrillation Management and Outcomes.
- World rank
- #213,427 of 7,710,434 ranked researchers
- Rank in Denmark
- #1,412 of 43,819
- Works
- 219
- Citations
- 10k
- Citations per work
- 46.5
What does Søren Lund Kristensen research?
Søren Lund Kristensen's work is mostly in Medicine (76%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences16575.5%
- Medicine16575.5%
- Everything else5424.5%
- 1Cardiology and Cardiovascular Medicine46% of their works
- 2Endocrinology, Diabetes and Metabolism12% of their works
- 3Epidemiology6% of their works
- 4Surgery5% of their works
- 5Pulmonary and Respiratory Medicine4% of their works
- 6Rheumatology3% of their works
Research topics
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Atrial Fibrillation Management and Outcomes
- Diabetes Treatment and Management
- Cardiac pacing and defibrillation studies
- Acute Myocardial Infarction Research
- Mechanical Circulatory Support Devices
- Antiplatelet Therapy and Cardiovascular Diseases
Which keywords describe Søren Lund Kristensen's research?
The keywords of their largest research topics: Heart Failure, Guidelines, Cardiovascular Disease, Diagnosis, Treatment, Echocardiography, Chamber Quantification and Diastolic Function.
- Aspirin
- Extracorporeal Membrane Oxygenation
- Acute Coronary Syndromes
- Cardiac Resynchronization Therapy
- Type 2 Diabetes
- Atrial Fibrillation
- Diastolic Function
- Echocardiography
- Diagnosis
- Guidelines
- Heart Failure
- Cardiovascular Disease
- Treatment
- Chamber Quantification
- Anticoagulant Therapy
- Cardiovascular Outcomes
- Percutaneous Coronary Intervention
- Implantable Cardioverter-Defibrillator
- Myocardial Infarction
- Left Ventricular Assist Device
- Clopidogrel
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Heart Failure1945 topics
- Guidelines1363 topics
- Cardiovascular Disease1002 topics
- Diagnosis831 topic
- Treatment831 topic
- Echocardiography662 topics
- Chamber Quantification481 topic
- Diastolic Function481 topic
- Anticoagulant Therapy361 topic
- Atrial Fibrillation361 topic
- Cardiovascular Outcomes321 topic
- Type 2 Diabetes321 topic
- Percutaneous Coronary Intervention252 topics
- Cardiac Resynchronization Therapy181 topic
- Implantable Cardioverter-Defibrillator181 topic
- Acute Coronary Syndromes171 topic
- Myocardial Infarction171 topic
- Extracorporeal Membrane Oxygenation131 topic
- Left Ventricular Assist Device131 topic
- Aspirin121 topic
- Clopidogrel121 topic
Where does Søren Lund Kristensen work?
Søren Lund Kristensen's main affiliation in the publication record is Rigshospitalet, Denmark.
How many publications and citations does Søren Lund Kristensen have?
OpenAlex counts 219 works and 10,184 citations for Søren Lund Kristensen, an h-index of 47, ranking #213,427 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Søren Lund Kristensen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.